Daymark Wealth Partners LLC Sells 96 Shares of The Clorox Company (NYSE:CLX)

Daymark Wealth Partners LLC reduced its position in The Clorox Company (NYSE:CLX) by 4.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,038 shares of the company’s stock after selling 96 shares during the period. Daymark Wealth Partners LLC’s holdings in Clorox were worth $331,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Eads & Heald Wealth Management raised its holdings in Clorox by 2.3% during the fourth quarter. Eads & Heald Wealth Management now owns 8,129 shares of the company’s stock worth $1,320,000 after buying an additional 180 shares during the last quarter. Ballentine Partners LLC increased its position in shares of Clorox by 5.4% during the fourth quarter. Ballentine Partners LLC now owns 2,608 shares of the company’s stock worth $424,000 after acquiring an additional 134 shares in the last quarter. Culbertson A N & Co. Inc. raised its holdings in shares of Clorox by 52.1% in the 4th quarter. Culbertson A N & Co. Inc. now owns 14,362 shares of the company’s stock worth $2,333,000 after acquiring an additional 4,919 shares during the last quarter. ZWJ Investment Counsel Inc. lifted its position in Clorox by 6.6% in the 4th quarter. ZWJ Investment Counsel Inc. now owns 1,918 shares of the company’s stock valued at $312,000 after acquiring an additional 118 shares in the last quarter. Finally, Kelly Financial Services LLC acquired a new position in Clorox during the 4th quarter valued at about $325,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Up 1.3 %

Clorox stock opened at $160.81 on Friday. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The company has a market capitalization of $19.90 billion, a P/E ratio of 56.03, a P/E/G ratio of 2.95 and a beta of 0.42. The firm has a 50 day moving average price of $163.93 and a 200-day moving average price of $157.11. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. Clorox’s revenue was up 27.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.49 earnings per share. As a group, equities analysts predict that The Clorox Company will post 6.87 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.03%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is currently 170.04%.

Analyst Ratings Changes

Several analysts have recently commented on the company. DA Davidson increased their price objective on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Evercore ISI lowered their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Barclays cut their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a report on Friday, January 17th. Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and upped their target price for the stock from $155.00 to $157.00 in a research note on Tuesday, January 7th. Finally, JPMorgan Chase & Co. raised their price target on shares of Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a research report on Thursday, January 16th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $156.54.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.